Eli Lilly and Company
TREATMENT OF CANCER WITH EXON 14 SKIPPING MUTATION(S) OR EXON 14 SKIPPING PHENOTYPE

Abstract:

The present invention provides a method of treating cancer with tumors bearing MET exon 14 skipping or MET exon 14 skipping phenotype comprising administering to a patient in need of such treatment an effective amount of the compound of Formula (I), or a pharmaceutically acceptable salt thereof: ##STR00001##